Skip to main content
OpenTrials

Clinical trial condition

Chronic Obstructive Pulmonary Disease, COPD

Explore clinical trials studying Chronic Obstructive Pulmonary Disease, COPD. Study availability and eligibility vary by location and protocol.

10 public trials 0 recruiting studies
Refine in advanced search Browse all conditions

Chronic Obstructive Pulmonary Disease, COPD trial results

Completed

A Safety, Tolerability and Efficacy Study With QBW251 in COPD Patients With QBW251

NCT02449018

Conditions
Bronchial Diseases, Bronchitis, Bronchitis, Chronic, +12 more
Locations
  • Novartis Investigative Site Birmingham, Alabama, United States
  • Novartis Investigative Site Fullerton, California, United States
  • Novartis Investigative Site Waterbury, Connecticut, United States
  • Novartis Investigative Site Clearwater, Florida, United States
View all 16 locations
View Trial Details
Completed

The HERO-study: Effects of Roflumilast in Patients With COPD (Chronic Obstructive Pulmonary Disease) (BY217/M2-121)

NCT00108823

Conditions
Chronic Disease, Chronic Obstructive Pulmonary Disease, COPD, Disease Attributes, +6 more
Locations
  • ALTANA Pharma Cities in California, California, United States
  • ALTANA Pharma Cities in Colorado, Colorado, United States
  • ALTANA Pharma Cities in Florida, Florida, United States
  • ALTANA Pharma Cities in Missouri, Missouri, United States
View all 16 locations
View Trial Details
Completed

Evaluation of Efficacy and Safety of Symbicort® as an add-on Treatment to Spiriva® in Patients With Severe COPD.

NCT00496470

Conditions
Chronic Disease, Chronic Obstructive Pulmonary Disease, COPD, Disease Attributes, +6 more
Locations
  • Research Site Concord, New South Wales, Australia
  • Research Site Sydney, New South Wales, Australia
  • Research Site Auchenflower, Queensland, Australia
  • Research Site Carina Heights, Queensland, Australia
View all 93 locations
View Trial Details

Related conditions